3Mitani H, Shirayama YY, Amada T, et al. Correlation between plasma levels of glutamate, alanine and serine with severity of depression [ J ]. Prog Neuropsychopharmacol Biol Psychiatry, 2006,30 ( 6 ) : 1155 - 1158.
4Hashimoto K,Sawa A, lyo M. Increased levels of glutamate in brains from patients with mood disorders [ J ]. Biol Psychiatry, 2007,62 (11) :1310 -1316.
5Miguel-Hidalgo JJ, Waltzer R, Whittom AA, et al. Glial and gluta- nmtergic markers in depression, alcoholism, and their comorbidity [ J ]. J Affect Disord,2010,127 ( 1 : 3 ) :230 - 240.
6Sun H,Guan L,Zhu Z,et al. Reduced levels of NR1 and NR2A with depression-like behavior in different brain regions in prenatally stressed juvenile offspring[ J]. PLoS One,2013,8 ( 11 ) :e81775.
7Heresco-Levy U, Javitt DC, Gelfin Y, et al. Controlled trial of D-cy- closerine adjuvant therapy for treatment-resistant major depressive dis- order[ J ]. J Affect Disord ,2006,93 ( 1 : 3 ) :239 - 243.
8Heresco-Levy U, Gelfin G, Bloeh B, et al. A randomized add-on trial of high-dose D-cycloserine for treatment-resistant depression[ J]. Int J Neuropsychopharmaco1,2013,16 ( 3 ) : 501 - 506.
9Teng CT,Demetrio FN. Memantine may acutely improve cognition and have a mood stabilizing effect in treatment-resistant bipolar disorder [ J ]. Rev Bras Psiquiatr,2006,28 ( 3 ) :252 - 254.
10Zarate CA,Singh J, BQuiroz JA, et al. A double-blind, placebo-con- trolled study of memantine in the treatment of major depression[ J:. Am J Psychiatry ,2006,163 ( 1 ) : 153 - 155.
5Insel T R, Wang P S. Rethinking Mental Illness[ J]. JAMA, 2010, 303(19) : 1970 - 1971.
6Kocsis J H, Leon A C, Markowitz J C, et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psycho- therapy, or their combination [ J ]. J Clin Psychiatry, 2009, 70 ( 3 ) : 354 - 361.
7Goto S, Terao T, Hoaki N, et al. Is serotonergic function associated with the antidepressant effects of modified-electreconvulsive therapy? [J]. J Affect Disord, 2012, 136(3) : 1062 -1066.
8Trivedi M H, Daly E J. Measurement-based care for refractory depres- sion : a clinical decision support model for clinical research and practice [J]. Drug Alcohol Depend, 2007, 88( Suppl 2) : S61 - S71.
9Gaynes B N, Rush A J, Trivedi M H, et al. Primary versus specialty care outcomes for depressed outpatients managed with measurement- based care: results from STAR * D[J]. J Gen Intern Meal, 2008, 23 (5) : 551 -560.
10Oller-Canet S, Fernandez-San-Martin M I, Garcia-Lecina R, et al. Do depressed patients comply with treatments prescribed?: a crass- sectional study of adherence to the antidepressant treatment[ J]. Actas Esp Psiquiatr, 2011, 39(5): 288-293.
